Beeinflussung des M. Dupuytren über die Ernährung und Mikronährstoffversorgung

Orientiert an den Risikofaktoren für die Entstehung eines Morbus Dupuytren, ist eine gezielte Analyse der Ernährungsgewohnheiten des Patienten sinnvoll. Schon kleine Veränderungen in der täglichen Routine der Nährstoffversorgung können das Risiko einer Verschlechterung oder eines Rezidivs reduzieren.

• Literatur

• 1 Ruettermann M, Hermann RM, Khatib-Chahidi K, Werker P. Morbus Dupuytren – Ätiologie und Behandlung. Dtsch Arztebl Int 2021; 118: 781-788
• 2 Deutsche Diabetes Gesellschaft. . Deutscher Gesundheitsbericht Diabetes 2020 – Die Bestandsaufnahme (14.11.2019). Im Internet: https://www.deutsche-diabetes-gesellschaft.de Stand: 21.03.2022
• 3 Kühn JP, Meffert P, Heske C. et al. Prevalence of fatty liver disease and hepatic iron overload in a northeastern German population by using quantitative MR imaging. Radiology 2017; 284: 706-716
• 4 Lean MEJ, Leslie WS, Barnes AC. et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019; 7: 344-355
• 5 Thom G, Messow CM, Leslie WS. et al. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med 2021; 38: e14395
• 6 Kloecker DE, Zaccardi F, Baldry E. et al. Efficacy of low- and very-low-energy diets in people with type 2 diabetes mellitus: A systematic review and meta-analysis of interventional studies. Diabetes Obes Metab 2019; 21: 1695-1705
• 7 Gow ML, Pham-Short A, Jebeile H. et al. Current perspectives on the role of very-low-energy diets in the treatment of obesity and type 2 diabetes in youth. Diabetes Metab Syndr Obes 2021; 14: 215-225
• 8 Gepner Y, Shelef I, Schwarzfuchs D. et al. Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial. Circulation 2018; 137: 1143-1157
• 9 Worm N. Beyond body weight-loss: Dietary strategies targeting intrahepatic fat in NAFLD. Nutrients 2020; 12: 1316
• 10 Gröber U. Arzneimittel und Mikronährstoffe. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2018
• 11 Prior RL, Gu L, Wu X. et al. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr 2007; 26: 170-181
• 12 Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutrition Journal 2004; 3: 5
• 13 ORAC-Infoportal. ORAC-Vergleichslisten (2022). Im Internet: http://orac-info-portal.de/orac_produkte/orac_vergleichslisten/ Stand: 21.03.2022
• 14 Lee CH, Fu Y, Yang SJ. et al. Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: A systematic review and meta-analysis. Nutrients 2020; 12: 2769
• 15 Park SK, Garland CF, Gorham ED. et al. Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. PloS One 2018; 13: e0193070
• 16 Shaikh AS, Guo X. The impact of antiepileptic drugs on vitamin levels in epileptic patients. Current Pharmaceutical Biotechnology 2018; 19: 674-681
• 17 Holló A, Clemens Z, Kamondi A. et al. Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study. Epilepsy Behav 2012; 24: 131-133
• 18 Degiorgio CM, Hertling D, Curtis A. et al. Safety and tolerability of Vitamin D3 5000 IU/day in epilepsy. Epilepsy Behav 2019; 94: 195-197